Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion description "[Because of the restricted expression of mRNA in B cell-lineage cells, IRTA2 is a new potential target for the immunotherapy of B cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion evidence source_evidence_literature NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion SIO_000772 15671532 NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion wasDerivedFrom befree-20140225 NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion wasGeneratedBy ECO_0000203 NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.